InsidersTradesSigma
Explore the complete record of transactions filed by Foster Alan Charles, Directeur Scientifique. Director active across 1 companies, notably Otonomy, INC.. Aggregated, 3 reports have been recorded. Total volume traded: €4k. The latest transaction was filed on 25 March 2022 — Cession. Regulator: SEC (Form 4). The full history is free.
3 of 3 declarations
Alan Charles Foster is Chief Scientific Officer at Otonomy, Inc. In this role, he is responsible for the scientific direction and research within the company. His expertise in science and clinical research is essential for the development of new treatments and technologies.